1. Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)†
Sattar N, et al. Lancet 2008;371:

2. Comparison of baseline characteristics by incidence of cardiovascular disease and diabetes in British Regional Heart Study (BRHS)
Sattar N, et al. Lancet 2008;371:

3. Participants in PROSPER (all and those with no cardiovascular disease at baseline) and in BRHS who fulfi l each definition of metabolic factor
Sattar N, et al. Lancet 2008;371:

4. Cumulative event rates by presence or absence
of metabolic syndrome and every metabolic factor at baseline, in participants without baseline vascular
disease in PROSPER
(A) Events of cardiovascular disease. (B) Events of incident diabetes. Criteria were: BMI≥30 kg/m² ; triglyceride≥1·69 mmol/L; HDL cholesterol <1·04 mmol/L
(men) or <1·29 mmol/L (women); fasting glucose≥6·1 mmol/L; and systolic blood pressure ≥130 mm Hg,
diastolic blood pressure≥85 mm Hg, or treated hypertensive.
CVD=cardiovascular disease.
BMI=body-mass index.
Sattar N, et al. Lancet 2008;371:

5. Hazard ratios (95% CIs) for events of cardiovascular disease and incident diabetes associated with metabolic syndrome, and individual criteria for metabolic syndrome
Sattar N, et al. Lancet 2008;371: